Welcome to the RIGHT THERAPY CONTEST 2019
As the leader in adsorptive extracorporeal blood depuration therapies Bellco, now part of Medtronic, is pleased to provide an opportunity to exchange relevant clinical experience to assess the impact of adsorptive dialysis therapies on your patient’s quality of life.
The goal of this contest is to facilitate healthcare professionals' collaboration and to share clinical best practice and application of adsorptive therapies.
Medtronic has a 40-year legacy of innovation that addresses the uniqueness of each patient and how personalization of treatment, the Right Therapy, can potentially lead to improved outcomes.
We invite you to share your case through the Right Therapy Contest website for review and consideration for sharing with your interested peers across the European geography.
Thank you in advance for your collaboration
Medtronic Renal Care Solutions Team
UPLOAD YOUR CASE
The aim of the contest is to collect Case Reports and/or clinical experiences on hemodialysis patients treated with Bellco adsorptive extracorporeal therapies as part of standard clinical practice. The contest is open to physicians based in Europe. An independent jury will evaluate the submissions and announce the best three Case Reports.
All Case Reports need to be composed of the following:
All data collected should refer to patients that have already been treated with Bellco therapies. Data should be retrospective, including both published and non-published Case Reports.
Case Reports cannot contain confidential or sensitive patient information, that could directly or indirectly identify a patient (e.g. name, age, date of treatment etc.). We reserve the right to censor the data provided if it contains confidential or sensitive patient data.
Data from ongoing clinical trials or collected specifically for the purpose of this contest will be excluded.
The scientific committee will evaluate every single submission based on the following criteria:
The authors can register and submit the Case Report on website from November 19, 2018.
The closing date for submissions is
May 3 May 5, 2019, 23.59 CET. Case Reports received after this date cannot be considered.
The authors of the three best abstracts will be invited to present their case at a Medtronic event.
At the end of the contest, all Case Reports will be collected and published in a special edition booklet, to be distributed by Medtronic, after approval from the authors.
The jury, formed by two European clinicians, has been selected by the Bellco Scientific Affairs Team based on their scientific curricula, expertise, and their experience with Bellco filtration adsorption therapies. The jury has no conflict of interest with Medtronic.
Further jury selection criteria includes the following:
A Master class meeting was held in Bologna on July 4th with the winners that had the opportunity to present their cases. Differently from the contest rules, the Jury final evaluation assigned 5 best cases divided into the following categories: Patients with Cardiovascular Risk, Patients with Inflammation and Malnutrition, Miscellaneous.
Category 1: Patients with Cardiovascular Risk
Category 2: Patients with Inflammation and Malnutrition
Category 3: Miscellaneous
RIGHT THERAPY CONTEST 2019 download all cases
THE RIGHT THERAPY FOCUS
Patients on dialysis can be challenging to treat due to many factors including advanced age and multiple comorbidities. A bibliography of clinical successes, published in relevant scientific journals or presented at international congresses, is reported on the following table to illustrate where clinical needs and dedicated therapies meet. Sharing these clinical best practices enables us to expand knowledge and understanding of this complex patient issue, and work together to address future challenges.
In the Right Therapy Table, you will find all references on Bellco Therapy solutions for patients in hemodialysis: